Syndax Pharmaceuticals Inc - Common Stock (SNDX)
CUSIP: 87164F105
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 88,260,257
- Total 13F shares
- 98,036,463
- Share change
- +9,231,771
- Total reported value
- $1,295,985,057
- Put/Call ratio
- 38%
- Price per share
- $13.22
- Number of holders
- 214
- Value change
- +$87,204,107
- Number of buys
- 113
- Number of sells
- 89
Quarterly Holders Quick Answers
What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164F105:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
9.3%
|
8,239,050
|
$158,601,714 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13D/G
13F
|
Company |
10%
|
8,520,000
|
$113,571,600 | $0 | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
5.6%
|
4,985,976
|
$95,980,040 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
4,886,974
|
$94,074,250 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
4.7%
|
4,105,313
|
$79,027,275 | — | 30 Sep 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.4%
|
3,888,437
|
$74,852,412 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
3,770,826
|
$72,588,401 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
3.1%
|
2,778,267
|
$53,481,635 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
2.8%
|
2,455,000
|
$47,258,750 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,977,082
|
$38,066,107 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.2%
|
1,925,300
|
$37,062,025 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.1%
|
1,896,032
|
$36,498,616 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
2%
|
1,763,277
|
$34,948,150 | — | 30 Sep 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
2%
|
1,731,191
|
$33,325,427 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
1,612,052
|
$31,032,002 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
1.3%
|
1,187,165
|
$22,852,926 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,119,963
|
$21,559,288 | — | 30 Sep 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
1.2%
|
1,090,984
|
$21,001,442 | — | 30 Sep 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.2%
|
1,034,846
|
$19,920,786 | — | 30 Sep 2024 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$19,731,250 | — | 30 Sep 2024 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.1%
|
1,000,000
|
$19,250,000 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
998,619
|
$19,222,554 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.1%
|
989,904
|
$19,055,654 | — | 30 Sep 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.1%
|
937,250
|
$18,042,063 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
887,145
|
$17,077,543 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1%
|
886,494
|
$17,065,010 | — | 30 Sep 2024 | |
| Commodore Capital LP |
13F
|
Company |
1%
|
885,000
|
$17,036,250 | — | 30 Sep 2024 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
0.99%
|
875,000
|
$16,843,750 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.93%
|
817,600
|
$15,738,800 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.89%
|
787,785
|
$15,165,000 | — | 30 Sep 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.89%
|
786,999
|
$15,149,731 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
786,990
|
$15,149,558 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.86%
|
757,307
|
$14,578,160 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
737,606
|
$14,198,916 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
695,947
|
$13,396,980 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.77%
|
683,202
|
$13,151,639 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.76%
|
669,352
|
$12,885,026 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.75%
|
664,765
|
$12,796,726 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.71%
|
627,679
|
$12,082,821 | — | 30 Sep 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.63%
|
554,103
|
$10,666,483 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.6%
|
526,702
|
$10,139,014 | — | 30 Sep 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.58%
|
508,283
|
$9,784,448 | — | 30 Sep 2024 | |
| Saturn V Capital Management LP |
13F
|
Company |
0.57%
|
501,978
|
$9,663,076 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.57%
|
500,000
|
$9,625,000 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.55%
|
486,228
|
$9,359,884 | — | 30 Sep 2024 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.54%
|
474,998
|
$9,144,000 | — | 30 Sep 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
0.54%
|
475,000
|
$9,143,750 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.53%
|
466,028
|
$8,971,039 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.52%
|
459,532
|
$8,845,991 | — | 30 Sep 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.51%
|
453,232
|
$8,724,716 | — | 30 Sep 2024 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q4 2024
As of 31 Dec 2024,
Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,036,463 shares.
The largest 10 holders included
BlackRock, Inc., Kynam Capital Management, LP, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, STEMPOINT CAPITAL LP, Soleus Capital Management, L.P., and Avoro Capital Advisors LLC.
This page lists
214
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
208
Q4 2024 holders
214
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.